Catinazzo Thomas 4
4 · Relay Therapeutics, Inc. · Filed Apr 30, 2025
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-29$3.23/sh−3,558$11,492→ 368,319 total - Sale
Common Stock
2025-04-30$3.00/sh−12,943$38,829→ 355,376 total - Sale
Common Stock
2025-04-28$3.17/sh−1,709$5,418→ 372,858 total - Sale
Common Stock
2025-04-28$3.17/sh−981$3,110→ 371,877 total
Footnotes (5)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,722 shares of restricted stock units ("RSUs") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 248,632 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
- [F4]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F5]Includes 206,240 shares underlying RSUs.